Neuroscience

Inaugural Cures Conference to be held on Thursday, February 5, 2026 in NYC

Panelists include leaders in the fields of science, medicine and technology: Jack Hidary, Dr. Edward Neilan, Dr. Shoshana Shendelman, Dr.…

6 days ago

BrainsWay Announces Draft Coverage Policy from Highmark® for Accelerated Deep TMS™

New draft policy from Highmark Blue Cross Blue Shield extends to both adolescent and adult depression patientsBURLINGTON, Mass. and JERUSALEM,…

7 days ago

Aytu BioPharma Recaps Investor Day Held on January 20, 2026

DENVER, CO / ACCESS Newswire / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical…

1 week ago

EQT Life Sciences co-leads EUR 51 million Series B in Exciva to advance its Alzheimer’s therapy into clinical Phase 2

Series B financing will support Exciva's Phase 2 clinical trial of its lead candidate, Deraphan, for agitation associated with Alzheimer's…

1 week ago

Concept Life Sciences Appoints Dr Adam Davenport as CSO to Strengthen Leadership in Integrated Drug Discovery

CHAPEL-EN-LE-FRITH, United Kingdom, Jan. 19, 2026 (GLOBE NEWSWIRE) -- Concept Life Sciences, a leading global contract research organization (CRO) specialising…

1 week ago

From Awareness to Action: Linus Health Drives the Next Era of Early Brain Health Detection

Expanding adoption, evidence, and innovation to support earlier identification and intervention across care and researchBOSTON, Jan. 16, 2026 /PRNewswire/ --…

2 weeks ago

Wonder Sciences Launches WondermedAI™ Provider Pilot During J.P. Morgan Healthcare Conference

Advanced AI Clinical Operating System Addresses Fragmentation in Mental Healthcare Through Coordinated, Data-Informed CareSAN FRANCISCO, Jan. 14, 2026 /PRNewswire/ --…

2 weeks ago

Wonder Sciences Launches WondermedAI™ Provider Pilot During J.P. Morgan Healthcare Conference

Advanced AI Clinical Operating System Addresses Fragmentation in Mental Healthcare Through Coordinated, Data-Informed CareSAN FRANCISCO, Jan. 14, 2026 /PRNewswire/ --…

2 weeks ago

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

14 abstracts will be presented across a range of neurological conditions including post‑stroke spasticity, cervical dystonia, blepharospasm and other movement…

2 weeks ago